Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2008, Vol. 35 Issue (2): 98-102    DOI:
Review Previous articles | Next articles
Placenta percreta presenting in the first trimester: Review of the literature
J. C. Papadakis1, *(), N. Christodoulou2
1Department of Obstetrics & Gynaecology, Venizelion General Hospital, Leoforos Knossou, Heraklion Crete
2Department of General Surgery Venizelion General Hospital, Leoforos Knossou, Heraklion Crete (Greece)
Download:  PDF(68KB)  ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Placenta percreta complicating pregnancy in the first trimester is extremely rare, and only a few cases have been reported in the literature. We recently reported on a patient with risk factors for placenta percreta that presented as first trimester fetal demise, unresponsive to medical management with prostaglandin. The patient required an emergency hysterectomy to control the bleeding after uterine curettage, and was complicated by severe consumption coagulopathy. This rare entity can lead to significant mortality and morbidity, particularly in the background of increased prevalence of the disease and its associated risk factors, and the large number of spontaneous and induced abortions performed worldwide. Therefore, we also reviewed all reported cases of first-trimester placenta percreta in the literature to increase the awareness of physicians and to highlight the clinical features and essentials of the management.
Key words:  Placenta accreta      Percreta      First trimester      Early pregnancy     
Published:  10 June 2008     
*Corresponding Author(s):  J. C. PAPADAKIS     E-mail:  juanpapadakis@doctors.org.uk

Cite this article: 

J. C. Papadakis, N. Christodoulou. Placenta percreta presenting in the first trimester: Review of the literature. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(2): 98-102.

URL: 

https://ceog.imrpress.com/EN/     OR     https://ceog.imrpress.com/EN/Y2008/V35/I2/98

[1] Mahmoud Alalfy, Soha Talaat Hamed, Alaa Sobhi Abd El Ghani, Ahmed Elgazzar, Amr Abbassy, Ahmed S. S. A. Rashwan, Omar Nagy, Mohamed A Shalaby, Hatem Hassan, Asmaa Ibrahem, Hesham Kamal, Reham Mahrous, Eman Kamal. The accuracy of 3D-TUI and 3D power Doppler using Alalfy simple criteria in the diagnosis of placenta accreta spectrum[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1132-1140.
[2] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[3] Mengdie Luo, Junxing Li, Xiaofeng Yang, Qiang Huang, Mengwei Huang, Jie Mei. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta spectrum disorder[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 487-493.
[4] Eren Akbaba. Can high transverse skin incision (Modified Maylard) be a new alternative in placenta accreta spectrum management with cesarean hysterectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 686-690.
[5] Yu Huang, Fang-Yuan Luo. Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 234-244.
[6] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[7] Wassan Nori, Muna Abdulghani, Ali B Roomi, Wisam Akram. To operate or to wait? Doppler indices as predictors for medical termination for first trimester missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 168-174.
[8] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[9] H.S. Song, Y.A. Kim. Placenta percreta at 33 weeks of gestation after laparoscopic radiofrequency ablation for adenomyosis and Conservative Surgical Treatment: A case report and review of literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 600-603.
[10] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[11] S.Y. Jung, H.Y. Cho, S.H. Lee, S. Lim, K.B. Lee. Pregnancy outcomes of a giant primary ovarian leiomyoma in the first trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 135-138.
[12] Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.
[13] T. Mihailovic, B. Kuanova, M. Terzic, S. Terzic, N. Arsenovic. Bilateral pulmonary agenesis diagnosed in the 13 th week of gestation - a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 479-481.
[14] J. Wang, T. Jiang, X. Zhu, G. Tian. Femur length in normal fetuses and the correlation between crown-rump length and gestational age at 11-14 weeks in a Chinese Han population: a preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 191-194.
[15] Y. E. Purut, E. E. Buyukbayrak, F. Ercan, A. Orcun, M. Menke, A. Y. Karageyim Karsidag. Do first trimester maternal serum follistatin like 3 levels predict preeclampsia and/or related adverse pregnancy outcomes?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 195-200.
No Suggested Reading articles found!